Papulonecrotic tuberculid in a human immunodeficiency virus type-1 patient with multidrug-resistant tuberculosis

被引：7
|
作者：
Fernandes, C
Maltez, F
Lourenço, S
Morgado, A
Proença, R
机构：
[1] Hosp Curry Cabral, Serv Dermatol, Dept Dermatol, P-1069 Lisbon, Portugal
[2] Hosp Curry Cabral, Dept Med & Infect Dis, P-1069 Lisbon, Portugal
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2004年 / 18卷 / 03期
关键词：
D O I：
10.1111/j.1468-3083.2004.00842.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：369 / 370
页数：2
相关论文
共 50 条
  • [1] Management of multidrug-resistant tuberculosis in human immunodeficiency virus patients
    Jamil, K. F.
    1ST INT CONF ON TROP MED & INFECT DIS FAC OF MED UNIV SUMATERA UTARA IN CONJUNCTION WITH THE 23RD NATL CONGRESS OF THE INDONESIAN SOC OF TROP & INFECT DIS CONSULTANT AND THE 18TH ANNUAL MEETING OF INTERNAL MED DEPT FAC OF MED UNIV SUMATERA UTARA, 2018, 125
  • [2] Poncet's disease and papulonecrotic tuberculid in a patient infected with the human immunodeficiency virus
    Cuende, E
    Almeida, V
    Portu, J
    Aldamiz, M
    Erdozain, MA
    Vesga, JC
    Saracibar, N
    ARTHRITIS AND RHEUMATISM, 1998, 41 (10): : 1884 - 1888
  • [3] BRONCHOESOPHAGEAL FISTULA DUE TO MULTIDRUG-RESISTANT TUBERCULOSIS IN A PATIENT INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    ASNIS, DS
    SALTZMAN, HP
    GIRON, JA
    CLINICAL INFECTIOUS DISEASES, 1995, 21 (04) : 1061 - 1062
  • [4] Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis
    Colby, Donn J.
    Kroon, Eugene
    Sacdalan, Carlo
    Gandhi, Monica
    Grant, Robert M.
    Phanuphak, Praphan
    Ananworanich, Jintanat
    Robb, Merlin L.
    Phanuphak, Nittaya
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (06) : 962 - 964
  • [5] Outcome of multidrug-resistant tuberculosis in human immunodeficiency virus-infected patients
    Franzetti, F
    Gori, A
    Iemoli, E
    Meraviglia, P
    Mainini, F
    Quirino, T
    degli Esposti, A
    degl'Innocenti, M
    Grassini, A
    Nardi, G
    Cargnel, A
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (03) : 553 - 560
  • [6] Papulonecrotic tuberculide in a human immunodeficiency virus type 1-seropositive patient
    Alsina, M
    Campo, P
    Toll, A
    Martinez, E
    Palou, J
    Herrero, C
    BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (01) : 232 - 233
  • [7] Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana
    Hafkin, J.
    Modongo, C.
    Newcomb, C.
    Lowenthal, E.
    MacGregor, R. R.
    Steenhoff, A. P.
    Friedman, H.
    Bisson, G. P.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (03) : 348 - 353
  • [8] Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection
    Brenner, BG
    Routy, JP
    Petrella, M
    Moisi, D
    Oliveira, M
    Detorio, M
    Spira, B
    Essabag, V
    Conway, B
    Lalonde, R
    Sekaly, RP
    Wainberg, MA
    JOURNAL OF VIROLOGY, 2002, 76 (04) : 1753 - 1761
  • [9] Multidrug resistant tuberculosis associated with human immunodeficiency virus
    Muntean, Petru Emil
    PNEUMON, 2019, 32 (04)
  • [10] Nosocomial transmission of human immunodeficiency virus and subsequent transmission of multidrug-resistant tuberculosis in a healthcare worker
    Ridzon, R
    Kenyon, T
    LuskinHawk, R
    Schultz, C
    Valway, S
    Onorato, IM
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1997, 18 (06): : 422 - 423
12345